The chemical class termed MEA-1 Activators comprises compounds that can potentially modulate the activity or expression of the MEA-1 protein through indirect mechanisms. These chemicals target various signaling pathways and cellular processes, creating environments that can influence MEA-1. Compounds such as Forskolin, by increasing cAMP levels, can modulate signaling pathways potentially intersecting with MEA-1's functions. Rapamycin, an mTOR inhibitor, and Metformin, an AMPK activator, impact cell growth, metabolism, and mitochondrial function, which can indirectly impact MEA-1. LY294002, a PI3K inhibitor, and SB203580, a p38 MAPK inhibitor, influence cell survival, proliferation, and stress responses, potentially impacting MEA-1.
Additionally, 2-Deoxy-D-glucose, a glycolysis inhibitor, and Curcumin, known for its broad effects on cellular signaling, can alter cellular energy metabolism and stress responses, influencing MEA-1. Resveratrol's activation of SIRT1, SP600125's inhibition of JNK, and Trichostatin A's effect on the epigenetic landscape also have potential indirect impacts on MEA-1. Y-27632, a ROCK inhibitor, affects cellular architecture, which may have implications for MEA-1's function. BAY 11-7082's inhibition of NF-κB activation could influence gene expression, potentially affecting MEA-1.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A ROCK inhibitor, impacting cell shape and motility. This could affect MEA-1 by altering cellular architecture and signaling related to cytoskeletal dynamics. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Inhibits NF-κB activation, potentially influencing the expression of a range of genes, possibly including those related to MEA-1's function or expression. | ||||||